New hope for dialysis patients: drug aims to stop blood pressure crashes
NCT ID NCT05834777
First seen Apr 29, 2026 · Last updated Jun 18, 2026 · Updated 13 times
Summary
This study tests whether a drug called icatibant can prevent sudden drops in blood pressure during dialysis, a common and serious problem. About 26 adults with kidney failure who often experience these drops will receive either the drug or a placebo in random order. The goal is to see if icatibant helps maintain stable blood pressure during treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRADIALYTIC HYPOTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vanderbilt Fresenius
RECRUITINGNashville, Tennessee, 37212, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.